|
|
1.
|
Association of Polymorphisms in FCGR2A and FCGR3A With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2-Positive Breast Cancer: Analysis of the NSABP B-31 Trial. MedStar authors:
Year: 2017
Citation: - JAMA Oncology. 3(3):335-341, 2017 Mar 01
Institution: - Washington Cancer Institute
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
All authors: - Bandos H, Costantino JP, Fehrenbacher L, Finnigan M, Gavin PG, Geyer CE Jr, Jeong JH, Johnson NL, Kim SR, Lipchik C, Mamounas EP, Paik S, Pogue-Geile KL, Rastogi P, Song N, Swain SM, Wickerham DL, Wolmark N
|
|
|
2.
|
Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic. MedStar authors:
Year: 2021
Citation: - Clinical and translational science. 14(2):589-598, 2021 03.
Institution: - MedStar Washington Hospital Center
Department: - Internal Medicine Residency
Medline publication type:
- Journal Article
- Research Support, N.I.H., Extramural
All authors: - Cavallari LH, Cicali EJ, Claudio-Campos K, Jerkins G, Marsiske M, Martin A, Mathews CA, Nainaparampil J, Nelson R, Padron A, Smith DM, Strekalova Y, Wiisanen K
|
